Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Derma Solution is a South Korean biotechnology company specializing in the development and manufacture of advanced aesthetic and regenerative medicine products. The company is a leader in the application of Polydeoxyribonucleotide (PDRN) technology, utilizing DNA fragments to stimulate cellular repair and collagen production. Their flagship product lines, including Elaxen and Rejuvenex, are widely used for skin rejuvenation, wound healing, and anti-aging treatments. In addition to PDRN-based solutions, Derma Solution produces a range of hyaluronic acid fillers and mesotherapy products designed for clinical dermatology and plastic surgery. The company maintains a strong global presence, exporting its medical-grade aesthetic solutions to numerous international markets. By focusing on high-purity extraction and innovative formulations, Derma Solution has established itself as a key player in the "K-Beauty" medical sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Derma Solution.